- cafead   Dec 20, 2022 at 11:02: AM
via
article source
- The potential market for the drug is huge If given the green light.
- The indication could haul in $500 million annually for the drugmaker.
- AstraZeneca is an intriguing mix of growth and pound-for-pound value.
article source